- Solve real problems with our hands-on interface
- Progress from basic puts and calls to advanced strategies
Interactive Options Course
Posted June 24, 2025 at 10:15 am
Use the Securities Lending Dashboard to analyze short sale metrics for these and other stocks.
Current IBKR clients can receive a free trial of the dashboard by clicking here.
| Rank | Stock | Description |
| 1 | CRWV | COREWEAVE INC-CL A |
| 2 | OKLO | OKLO INC |
| 3 | CRCL | CIRCLE INTERNET GROUP INC |
| 4 | ASTS | AST SPACEMOBILE INC |
| 5 | RGTI | ARIGETTI COMPUTING INC |
| 6 | NIO | NIO INC – ADR |
| 7 | QUBT | QUANTUM COMPUTING INC |
| 8 | SYM | SYMBOTIC INC |
| 9 | LI | LI AUTO INC – ADR |
| 10 | DJT | TRUMP MEDIA & TECHNOLOGY GRO |
| Rank | ETF | Description |
| 1 | VXX | IPATH SERIES B S&P 500 VIX |
| 2 | ARKK | ARK INNOVATION ETF |
| 3 | XBI | SPDR S&P BIOTECH ETF |
| 4 | IBIT | ISHARES BITCOIN TRUST ETF |
| 5 | TNA | DIREXION DLY SM CAP BULL 3X |
| 6 | RYLD | GLOBAL X RUSSELL 2000 COV CL |
| 7 | XRT | SPDR S&P RETAIL ETF |
| 8 | YINN | DRX DLY FTSE CHINA BULL 3X |
| 9 | USO | UNITED STATES OIL FUND LP |
| 10 | YANG | DRX DLY FTSE CHINA BEAR 3X |
| Rank | Stock | Description |
| 1 | CRWV | COREWEAVE INC-CL A |
| 2 | CRCL | CIRCLE INTERNET GROUP INC |
| 3 | RGC | REGENCELL BIOSCIENCE HOLDING |
| 4 | SRM | SRM ENTERTAINMENT INC |
| 5 | QUBT | QUANTUM COMPUTING INC |
| 6 | HUSA | HOUSTON AMERICAN ENERGY CORP |
| 7 | APVO | APTEVO THERAPEUTICS INC |
| 8 | CERO | CERO THERAPEUTICS HOLDINGS I |
| 9 | RBNE | ROBIN ENERGY LTD |
| 10 | DWSN | DAWSON GEOPHYSICAL CO |
| Rank | ETF | Description |
| 1 | VXX | IPATH SERIES B S&P 500 VIX |
| 2 | USO | UNITED STATES OIL FUND LP |
| 3 | UVIX | 2X LONG VIX FUTURES ETF |
| 4 | ARKK | ARK INNOVATION ETF |
| 5 | MSTX | DEFIANCE DLY TRG 2X LNG MSTR |
| 6 | JNUG | DIREXION DAILY JUNIOR GOLD M |
| 7 | QABA | FIRST TRUST NASDAQ ABA CBIF |
| 8 | YINN | DRX DLY FTSE CHINA BULL 3X |
| 9 | DRIP | DIREXION DAILY S&P OIL & GAS |
| 10 | MSTU | T-REX 2X LONG MSTR DT ETF |
| Rank | Stock | Description |
| 1 | XTIA | XTI AEROSPACE INC |
| 2 | RGC | REGENCELL BIOSCIENCE HOLDING |
| 3 | SBET | SHARPLINK GAMING INC |
| 4 | KNW | KNOW LABS INC |
| 5 | QNTM | QUANTUM BIOPHARMA LTD |
| 6 | KZIA | KAZIA THERAPEUTICS-SPON ADR |
| 7 | UPXI | UPEXI INC |
| 8 | HUSA | HOUSTON AMERICAN ENERGY CORP |
| 9 | ZENA | ZENATECH INC |
| 10 | TMDE | TMD ENERGY LTD |
| Rank | ETF | Description |
| 1 | SMST | DEFIANCE DLY TRG 2X SHR MSTR |
| 2 | LABD | DRX DLY S&P BIOTECH BEAR 3X |
| 3 | NVDQ | T-REX 2X INVERSE NVIDIA DLY |
| 4 | GMEU | T-REX 2X LONG GME DLY TA ETF |
| 5 | VIXY | PROSHARES VIX SHORT-TERM FUT |
| 6 | MSTX | DEFIANCE DLY TRG 2X LNG MSTR |
| 7 | SMCX | DEFIANCE DLY TRG 2X LNG SMCI |
| 8 | TMV | DRX DLY 20+ YR TREAS BEAR 3X |
| 9 | BNO | UNITED STATES BRENT OIL FUND |
| 10 | RPAR | RPAR RISK PARITY ETF |
The analysis in this material is provided for information only and is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad-based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation by IBKR to buy, sell or hold such investments. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Interactive Brokers, its affiliates, or its employees.
Any discussion or mention of an ETF is not to be construed as recommendation, promotion or solicitation. All investors should review and consider associated investment risks, charges and expenses of the investment company or fund prior to investing. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Related Articles
Join The Conversation
For specific platform feedback and suggestions, please submit it directly to our team using these instructions.
If you have an account-specific question or concern, please reach out to Client Services.
We encourage you to look through our FAQs before posting. Your question may already be covered!